We also further analyzed the expression of MEG3 in different grades of gliomas, finding that the expression level of MEG3 in grade 4 was significantly lower than that in other grades of gliomas and normal control, it decreased with the increasing of malignant degree of gliomas (Figure 1C). The gene discussed is MEG3; the disease is central nervous system cancer.